Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
David H. Roman
Globus Medical Downgraded By Goldman, Sees 11% Downside
Goldman Is Downgrading Abbott Laboratories
UPDATE: Goldman Sachs Downgrades Baxter International as Increased Dependence on Pipeline Raises Risk
Goldman Is Downgrading Abbott Laboratories
UPDATE: Goldman Sachs Downgrades Baxter International as Increased Dependence on Pipeline Raises Risk
UPDATE: Goldman Sachs Upgrades C.R. Bard as Elements Driving Sell Thesis are Resolved
UPDATE: Goldman Sachs Downgrades NuVasive as Industry Headwinds, Valuation Pose Downside Risk
UPDATE: Goldman Sachs Upgrades C.R. Bard as Elements Driving Sell Thesis are Resolved
UPDATE: Goldman Sachs Downgrades NuVasive as Industry Headwinds, Valuation Pose Downside Risk
UPDATE: Goldman Sachs Downgrades Globus Medical as Execution, Share Gains are Offset by Valuation
UPDATE: Goldman Sachs Upgrades Thoratec on Good Upside Potential
Read More...
David H. Roman Recent News
UPDATE: Goldman Sachs Upgrades Zeltiq Aesthetics on Good Upside from Current Levels
UPDATE: Goldman Sachs Downgrades Intuitive Surgical on Disappointing 2Q2013 Results
UPDATE: Goldman Sachs Downgrades Hill-Rom Holdings on Outperformance
UPDATE: Goldman Sachs Announces Neutral Rating on Covidien to Reflect New MNK Spin Off
Goldman Sachs Reiterates Buy Rating on Edwards Lifesciences Following Detailed Thesis Review
UPDATE: Goldman Sachs Upgrades Abbott Laboratories; Growth Is Poised To Accelerate
UPDATE: Goldman Sachs Downgrades Thoratec Accounting on Challenged Outer Year Growth